HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The stereoselective effects of bucolome on the pharmacokinetics and pharmacodynamics of racemic warfarin.

Abstract
The objective of this study was to investigate the stereoselective influence of bucolome on the pharmacokinetics and pharmacodynamics of warfarin in Japanese inpatients with heart disease. Thirty patients were administered a fixed-maintenance dose of warfarin alone once a day for at least 7 days. The other 25 patients were concomitantly administered warfarin and a 300 mg dose of bucolome once a day, and blood samples were collected on days 1, 4, 7, 14, or 21 after administration of bucolome. Serum concentration of warfarin enantiomers was measured by a chiral reversed-phase HPLC-ultraviolet detection method. The PT-INR was used as a measure of the pharmacodynamic effect of warfarin. Coadministration of bucolome and warfarin had no effect on serum (R)-warfarin concentration and significantly increased serum (S)-warfarin concentration compared with warfarin alone. The PT-INR of warfarin alone was significantly lower with bucolome cotreatment. These results indicate that the augmented anticoagulant effect of warfarin by bucolome is due to inhibition of (S)-warfarin metabolism in vivo. When bucolome is added to a stabilized regimen of warfarin therapy, the dose of warfarin should be reduced by about 30% to 60%, and caution should be exercised during the first 7 days after coadministration of bucolome.
AuthorsK Matsumoto, S Ishida, K Ueno, H Hashimoto, M Takada, K Tanaka, S Kamakura, K Miyatake, M Shibakawa
JournalJournal of clinical pharmacology (J Clin Pharmacol) Vol. 41 Issue 4 Pg. 459-64 (Apr 2001) ISSN: 0091-2700 [Print] England
PMID11304904 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Anticoagulants
  • Barbiturates
  • Warfarin
  • bucolome
Topics
  • Administration, Oral
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Inflammatory Agents, Non-Steroidal (therapeutic use)
  • Anticoagulants (pharmacokinetics)
  • Barbiturates (administration & dosage, pharmacology, therapeutic use)
  • Dose-Response Relationship, Drug
  • Drug Interactions
  • Female
  • Heart Diseases (drug therapy)
  • Humans
  • Japan
  • Male
  • Metabolic Clearance Rate
  • Middle Aged
  • Stereoisomerism
  • Time Factors
  • Warfarin (administration & dosage, pharmacokinetics, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: